277 related articles for article (PubMed ID: 37711895)
41. Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1.
Anzick SL; Azorsa DO; Simons SS; Meltzer PS
BMC Cancer; 2003 Sep; 3():22. PubMed ID: 12964942
[TBL] [Abstract][Full Text] [Related]
42. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
Haugan Moi LL; Hauglid Flågeng M; Gandini S; Guerrieri-Gonzaga A; Bonanni B; Lazzeroni M; Gjerde J; Lien EA; DeCensi A; Mellgren G
Clin Cancer Res; 2010 Apr; 16(7):2176-86. PubMed ID: 20332317
[TBL] [Abstract][Full Text] [Related]
43. The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.
Lahusen T; Henke RT; Kagan BL; Wellstein A; Riegel AT
Breast Cancer Res Treat; 2009 Jul; 116(2):225-37. PubMed ID: 19418218
[TBL] [Abstract][Full Text] [Related]
44. Expression of AIB1 protein as a prognostic factor in breast cancer.
Lee K; Lee A; Song BJ; Kang CS
World J Surg Oncol; 2011 Oct; 9():139. PubMed ID: 22035181
[TBL] [Abstract][Full Text] [Related]
45. Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1.
Fleming FJ; Myers E; Kelly G; Crotty TB; McDermott EW; O'Higgins NJ; Hill AD; Young LS
J Clin Pathol; 2004 Oct; 57(10):1069-74. PubMed ID: 15452162
[TBL] [Abstract][Full Text] [Related]
46. Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.
Alkner S; Jensen MB; Rasmussen BB; Bendahl PO; Fernö M; Rydén L; Mouridsen H;
Breast Cancer Res Treat; 2017 Nov; 166(2):481-490. PubMed ID: 28766132
[TBL] [Abstract][Full Text] [Related]
47. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
48. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
[TBL] [Abstract][Full Text] [Related]
49. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
[TBL] [Abstract][Full Text] [Related]
50. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
[TBL] [Abstract][Full Text] [Related]
51. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT
Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804
[TBL] [Abstract][Full Text] [Related]
52. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells.
Fenne IS; Helland T; Flågeng MH; Dankel SN; Mellgren G; Sagen JV
PLoS One; 2013; 8(7):e70096. PubMed ID: 23936147
[TBL] [Abstract][Full Text] [Related]
54. Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?
Grivas PD; Tzelepi V; Sotiropoulou-Bonikou G; Kefalopoulou Z; Papavassiliou AG; Kalofonos H
Int J Colorectal Dis; 2009 Jun; 24(6):613-22. PubMed ID: 19198856
[TBL] [Abstract][Full Text] [Related]
55. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
Ma G; Ren Y; Wang K; He J
Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
[TBL] [Abstract][Full Text] [Related]
56. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.
Oh A; List HJ; Reiter R; Mani A; Zhang Y; Gehan E; Wellstein A; Riegel AT
Cancer Res; 2004 Nov; 64(22):8299-308. PubMed ID: 15548698
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
58. Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor.
Zheng FF; Wu RC; Smith CL; O'Malley BW
Mol Cell Biol; 2005 Sep; 25(18):8273-84. PubMed ID: 16135815
[TBL] [Abstract][Full Text] [Related]
59. Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.
Redmond AM; Bane FT; Stafford AT; McIlroy M; Dillon MF; Crotty TB; Hill AD; Young LS
Clin Cancer Res; 2009 Mar; 15(6):2098-106. PubMed ID: 19276281
[TBL] [Abstract][Full Text] [Related]
60. The role of SRC-3 in human breast cancer.
Gojis O; Rudraraju B; Gudi M; Hogben K; Sousha S; Coombes RC; Cleator S; Palmieri C
Nat Rev Clin Oncol; 2010 Feb; 7(2):83-9. PubMed ID: 20027190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
